1589966483433848834

#GamidaCell presents #GDA501, a #NAMenabled genetically modified NK Cell candidate, demonstrating promising antitumor activity against HER2+ cancers at the #SITC 37th Annual Meeting.

Learn More: https://t.co/MYdcpvg7Py https://t.co/FVM58XnmYC

Send us a message